This topic contains a solution. Click here to go to the answer

Author Question: Olestra is a fake fat and may have adverse affects. Indicate whether the statement is true or ... (Read 41 times)

Brittanyd9008

  • Hero Member
  • *****
  • Posts: 500
Olestra is a fake fat and may have adverse affects.
  Indicate whether the statement is true or false

Question 2

One of the factors that increases the risk of MODS is _____.
 a. age over 40 years
 b. length of hospital stay
  c. malnutrition
 d. underweight
 e. gender



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

vickybb89

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

True

Answer to Question 2

c




Brittanyd9008

  • Member
  • Posts: 500
Reply 2 on: Aug 19, 2018
Thanks for the timely response, appreciate it


samiel-sayed

  • Member
  • Posts: 337
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Walt Disney helped combat malaria by making an animated film in 1943 called The Winged Scourge. This short film starred the seven dwarfs and taught children that mosquitos transmit malaria, which is a very bad disease. It advocated the killing of mosquitos to stop the disease.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library